Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease

MOGAD comes of age with new criteria

(2023) Francesc Graus et al.   LANCET NEUROLOGY

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

(2023) Brenda Banwell et al.   LANCET NEUROLOGY

The State of the Art of Pediatric Multiple Sclerosis

(2023) Raluca Ioana Teleanu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients

(2023) Monica Margoni et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Central Vein Sign in Pediatric Multiple Sclerosis and MOG Antibody Associated Disease

(2023) Kimystian Harrison et al.   PEDIATRIC NEUROLOGY

Incorporating the Central Vein Sign Into the Diagnostic Criteria for Multiple Sclerosis

(2023) Daniel Ontaneda et al.   JAMA Neurology

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease

(2023) Osman Corbali et al.   Frontiers in Neurology

Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis

(2022) Omar Al-Louzi et al.   Neurology-Neuroimmunology & Neuroinflammation

MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls

(2022) Cristina M. Gaudioso et al.   ANNALS OF NEUROLOGY

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis

(2022) Isobel Meaton et al.   Multiple Sclerosis Journal

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

(2022) Rosa Cortese et al.   NEUROLOGY

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome

(2022) Eva Maria Wendel et al.   Neurology-Neuroimmunology & Neuroinflammation

Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study

(2022) Vincenzo Daniele Boccia et al.   Multiple Sclerosis Journal

Is the central vein sign a useful diagnostic marker for paediatric-onset multiple sclerosis?

(2022) Omar Abdel-Mannan et al.   Multiple Sclerosis Journal

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel

(2021) Livnat Brill et al.   Frontiers in Neurology

QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions

(2021) Kelly M. Gillen et al.   Annals of Clinical and Translational Neurology

Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica

(2021) John R Ciotti et al.   Multiple Sclerosis Journal

Paramagnetic Rim Lesions in Multiple Sclerosis: Comparison of Visualization at 1.5-T and 3-T MRI

(2021) Christopher C. Hemond et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

(2020) Romana Höftberger et al.   ACTA NEUROPATHOLOGICA

MOG Antibody Associated Disease: How it Differs From and Resembles Other Neuroinflammatory Disorders

(2020) Mona Shahriari et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

(2020) Alvaro Cobo‐Calvo et al.   ANNALS OF NEUROLOGY

Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI

(2020) Assunta Dal-Bianco et al.   BRAIN

The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis

(2020) Marco Castellaro et al.   Diagnostics

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults

(2019) CL de Mol et al.   Multiple Sclerosis Journal

Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort

(2019) Yael Hacohen et al.   Multiple Sclerosis Journal

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo

(2019) Martina Absinta et al.   JAMA Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis

(2018) Jiraporn Jitprapaikulsan et al.   OPHTHALMOLOGY

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

(2018) Yael Hacohen et al.   JAMA Neurology

Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome

(2018) John J. Chen et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging

(2016) Assunta Dal-Bianco et al.   ACTA NEUROPATHOLOGICA

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions

(2016) Martina Absinta et al.   JOURNAL OF CLINICAL INVESTIGATION

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

(2016) Pascal Sati et al.   Nature Reviews Neurology

Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions

(2013) Veela Mehta et al.   PLoS One

2010 McDonald criteria for diagnosing pediatric multiple sclerosis

(2012) Yair Sadaka et al.   ANNALS OF NEUROLOGY

Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition

(2011) Wei Li et al.   NEUROIMAGE

FSL

(2011) Mark Jenkinson et al.   NEUROIMAGE